Connor, Clark & Lunn Investment Management (CC&L)
TCRR

Connor, Clark & Lunn Investment Management (CC&L)’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio TCRR Stock Details TCRR Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-14,362
Closed -$26K – 1482
2022
Q3 		$26K Buy
+14,362
New +$26K ﹤0.01% 1077
2022
Q1 		– Sell
-28,760
Closed -$134K – 1271
2021
Q4 		$134K Buy
28,760
+4,443
+18% +$20.7K ﹤0.01% 1013
2021
Q3 		$207K Buy
+24,317
New +$207K ﹤0.01% 942